Pharmaceutical and healthcare market in Poland 2009
Published By: PMR Ltd.
June 2009
R320-164
PDF E-mail From Publisher $3,666.55
Global License, CD-ROM Mail Delivery $9,166.37
Description
The report comprises the complete economic analysis of pharmaceutical sector in Poland as well as recent data on healthcare sector in the region and contains forecast projections for 2009-2011.
The value data are presented for the total market, pharmacy and hospital segment, Rx, foreign and domestic drugs, generic and innovative medicines, and main ATC categories together with forecasts.
The report offers insights into ongoing trends, taking a closer look at areas of growth and decline. Factors that influence the market, from epidemiology to consumer behaviour, are studied and presented for your thorough understanding of the market. Economic data, such as employment and cost-revenue analysis of the pharmaceutical sector, are also covered.
Our analysis also takes into account the latest changes in reimbursement and legislation (latest and expected). The impact of global financial crisis has also been analysed and taken into consideration in the forecasts provided for the size of the Polish pharmaceutical and healthcare market by the PMR team of pharmaceutical analysts and economists.
If you are looking for:
- detailed information on legal environment together with most important changes in the “minor” and “major” amendments to the Pharmaceutical Act, analysis of changes is Act on Healthcare Services Financed from Public Funds
- analysis of latest novelisations of reimbursement lists and their impact on the market
- profiles of largest players active on pharma market
- strategic key data
- data needed for market entry
- description of epidemiologic and demographic trends
- economic trends analysis
- consumer behaviour in Poland analysis
|
Table of Contents
- Report methodology
- Executive summary
- Overview of the pharmaceutical market in Poland
- Key events and trends in 2008-2009
- Key events and trends anticipated for 2009-2010
- Size of Polish pharmaceutical market
- Pharmaceutical market in 2002-2011
- Pharmacy sales in 2002-2008
- Development forecasts for pharmacy sales in 2009-2011
- Number of packages sold in 2002-2008
- Domestic and foreign pharmaceuticals
- Original and generic pharmaceuticals
- Overview of the hospital drug market in Poland
- Value of hospital market in 2000-2010
- Financial standing of public healthcare facilities
- Drug therapy programmes
- Spending on chemotherapy
- Drug prices
- Average drug prices on the pharmacy market
- Average drug prices on the hospital market
- Average prices of domestic and foreign pharmaceuticals
- Prices on aggregate pharmacy market
- Prices of Rx drugs
- Prices of refunded drugs
- Average prices of innovative and generic drugs
- Average prices in therapeutic groups
- Analysis of ATC groups, showcasing Rx drugs
- Analysis of ATC subgroups, showcasing Rx drugs
- Average prices of concern drugs
- Prices on the pharmacy market
- Rx drug prices
- Drug prices in Poland and in other European countries
- Drug reimbursement in Poland
- NFZ expenditure on drug reimbursement
- Share of reimbursement in pharmacy trade
- Structure of drug reimbursement
- Reimbursement structure by reimbursement type
- Reimbursement structure by therapeutic groups
- Reimbursement structure by domestic and foreign drugs
- Reimbursement structure by active substances
- Reimbursement structure by product
- Reimbursement structure by manufacturer
- Legislative changes and their impact on the drug reimbursement market
- New reimbursement lists
- Amendment to Pharmaceutical Law
- Foreign trade
- Export
- Import
- Pharmacy market by therapeutic groups
- Market value shares of ATC groups
- Pharmacy market
- Rx market
- Market volume shares of ATC groups
- Pharmacy market
- Rx market
- Alimentary tract and metabolism
- Market size and forecasts
- Key categories of drugs used in alimentary tract and metabolic diseases
- Drugs used in diabetes
- Vitamins and mineral supplements
- Antacids, antiflatulents and anti-ulcerants
- Antidiarrhoeals, oral electrolyte replacers and intenstinal anti-inflammatories
- Antiobesity preparations
- Best selling preparations
- Cardiovascular system
- Market size and forecasts
- Key categories of drugs used in cardiovascular diseases
- Agents acting on the renin-angiotensin system
- Lipid regulators
- Beta blocking agents
- Antihypertensives
- Best selling preparations
- Central nervous system
- Market size and forecasts
- Key categories of drugs used in central nervous system diseases
- Analgesics
- Psycholeptics
- Psychoanaleptics
- Best selling preparations
- Respiratory system
- Market size and forecasts
- Key categories of drugs used in respiratory system diseases
- Anti-asthma and COPD products
- Cough and cold preparations
- Systemic antihistamines
- Nasal preparations
- Best selling preparations
- Anti-infectives
- Market size and forecasts
- Key categories of anti-infectives
- Systemic antibacterials
- Vaccines
- Best selling preparations
- Musculo-skeletal system
- Market size and forecasts
- Key categories of drugs used in musculo-skeletal diseases
- Anti-inflammatory and anti-rheumatic products
- Topical anti-rheumatics
- Drugs for disorders of the musculo-skeletal system
- Best selling preparations
- Genito-urinary system
- Market size and forecasts
- Key categories of drugs affecting genito-urinary system
- Sex hormones and products with similar desired effects, systemic use only
- Urologicals
- Best selling preparations
- Dermatologicals
- Market size and forecasts
- Key categories of dermatologicals
- Topical corticosteroids
- Dermatological antifungals
- Best selling preparations
- Blood and blood forming organs
- Market size and forecasts
- Key categories of drugs used in diseases of the blood and blood forming organs
- Antithrombotic agents
- Anti-anaemic preparations
- Best selling preparations
- Antineoplastic and immunomodulating agents
- Market size and forecasts
- Key categories of antineoplastic and immunomodulating agents
- Cytostatic hormone therapy
- Immunostimulating agents
- Immunosuppressants
- Best selling preparations
- Other ATC groups
- Sensory organs
- Systemic hormonal preparations
- Parasitology
- Various
- Pharmaceutical companies in Poland
- Number and classification of pharmaceutical manufacturers in Poland
- Manufacturers of pharmaceutical substances
- Drug manufacturers
- Economic analysis of Polish pharmaceutical sector
- Output of selected pharmaceutical products
- Revenues
- Profit
- Operating expenses
- Employment
- Staffing levels
- Labour productivity
- Average remuneration
- Investments in the Polish pharmaceutical sector in 2006
- Investment number
- Investment value
- Largest foreign investments in Polish pharmaceutical industry 2007-2008
- Expenditure on intangible fixed assets
- Top drug makers in Poland
- Top players on pharmacy market
- Top players on the Rx market
- Profiles of key players
- Demographic trends
- Population
- Natural population growth
- Ageing of society
- Life expectancy
- Gender structure
- Degree of urbanisation
- Epidemiological trends
- The main health problems of Poles
- Main causes of death
- Key statistics
- Poland compared with other European countries
- Epidemiology of selected diseases in Polish society
- Cardiovascular system diseases
- Neoplasms
- Diseases of the central nervous system
- Respiratory system diseases
- Diseases of the alimentary tract and metabolism
- Consumer behaviour
- Health assessment
- What do Poles do to be healthy?
- Sources of information about health and illnesses
- Poles’ opinion about generic drugs
- Poles’ opinions about innovative drugs
- Factors influencing the purchase of OTC drugs
- Frequency of OTC drug purchases
- Most popular OTC drugs
- Place of purchase of OTC drugs
- Drug use in illness
- Macroeconomic trends
- GDP growth
- Inflation
- Unemployment
- Wages
- Regulatory environment
- Regulations and institutions governing the pharmaceutical market in Poland
- Key changes introduced by the “large amendment” to the Pharmaceutical Law
- Key changes introduced by the amended Healthcare Act
- Anti-corruption provisions
- Changes in reimbursement process
- Greater control over the NFZ
- Ordinance on Drug Advertising
- Visits of medical representatives at public healthcare centres
- Simultaneous advertising of several products
- Risk warnings
- Ban on audiovisual advertising in pharmacies
- Compliance with Medicinal Product Characteristics
- Transition provisions
- Key amendments introduced by the “minor amendment” to the Pharmaceutical Law
- Fixed prices and margins for reimbursed drugs
- Anti-concentration regulations
- Ban on advertising pharmacies
- Changes in monitoring adverse reactions
- Other regulations
- Harmonisation of registration documentation
- URPL Act
- Distribution
- Key events and trends on the distribution market in 2007-2009
- Trends expected on the distribution market in 2009-2011
- Key players on the drug distribution market
- Pharmaceutical wholesalers
- Wholesalers in Poland: number and business profiles
- The largest players on the Polish wholesale market
- Pharmacy distribution
- Pharmacy count
- Financial standing of Polish pharmacies
- Pharmacy chains
- Internet pharmacies
- Healthcare market in Poland
- Healthcare system in Poland
- Sources of financing of the public healthcare system
- Healthcare financing
- Healthcare costs
- Market of private medical services in Poland
- Other data on health care in Poland
- List of graphs
- List of tables
- About PMR
- About PharmaExpert
|
Order Form * Please reference product number R320-164 when ordering or inquiring.
MindBranch, Inc.,
131 Ashland St., Suite 200 North Adams, MA 01247
tel: 800-774-4410
fax: +1-413-664-9791
www.mindbranch.com
|
